These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 14534508)

  • 1. Lp-PLA2: a new marker of vascular risk.
    Med Lett Drugs Ther; 2003 Oct; 45(1167):83. PubMed ID: 14534508
    [No Abstract]   [Full Text] [Related]  

  • 2. Lp-PLA2: an emerging biomarker of coronary heart disease.
    Dada N; Kim NW; Wolfert RL
    Expert Rev Mol Diagn; 2002 Jan; 2(1):17-22. PubMed ID: 11963798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between Lp-PLA2 and coronary artery disease: focus on its relationship with lipoproteins and markers of inflammation and hemostasis.
    Khuseyinova N; Imhof A; Rothenbacher D; Trischler G; Kuelb S; Scharnagl H; Maerz W; Brenner H; Koenig W
    Atherosclerosis; 2005 Sep; 182(1):181-8. PubMed ID: 16115490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein-associated phospholipase A2 is an independent marker for coronary endothelial dysfunction in humans.
    Yang EH; McConnell JP; Lennon RJ; Barsness GW; Pumper G; Hartman SJ; Rihal CS; Lerman LO; Lerman A
    Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):106-11. PubMed ID: 16239595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of statin therapy on lipoprotein associated phospholipase A2 levels.
    Albert MA; Glynn RJ; Wolfert RL; Ridker PM
    Atherosclerosis; 2005 Sep; 182(1):193-8. PubMed ID: 15982658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of lipoprotein-associated phospholipase A2 levels with coronary artery disease risk factors, angiographic coronary artery disease, and major adverse events at follow-up.
    Brilakis ES; McConnell JP; Lennon RJ; Elesber AA; Meyer JG; Berger PB
    Eur Heart J; 2005 Jan; 26(2):137-44. PubMed ID: 15618069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evolving story of lipoprotein-associated phospholipase A2 in atherosclerosis and cardiovascular risk prediction.
    Macphee CH; Nelson JJ
    Eur Heart J; 2005 Jan; 26(2):107-9. PubMed ID: 15618064
    [No Abstract]   [Full Text] [Related]  

  • 8. Lipoprotein-associated phospholipase A2 adds to risk prediction of incident coronary events by C-reactive protein in apparently healthy middle-aged men from the general population: results from the 14-year follow-up of a large cohort from southern Germany.
    Koenig W; Khuseyinova N; Löwel H; Trischler G; Meisinger C
    Circulation; 2004 Oct; 110(14):1903-8. PubMed ID: 15451783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein-associated phospholipase A2 protein expression in the natural progression of human coronary atherosclerosis.
    Kolodgie FD; Burke AP; Skorija KS; Ladich E; Kutys R; Makuria AT; Virmani R
    Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2523-9. PubMed ID: 16960105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical review: Lipoprotein-associated phospholipase A2, a novel inflammatory biomarker and independent risk predictor for cardiovascular disease.
    Sudhir K
    J Clin Endocrinol Metab; 2005 May; 90(5):3100-5. PubMed ID: 15713711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein-associated phospholipase A2 predicts future cardiovascular events in patients with coronary heart disease independently of traditional risk factors, markers of inflammation, renal function, and hemodynamic stress.
    Koenig W; Twardella D; Brenner H; Rothenbacher D
    Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1586-93. PubMed ID: 16627803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study.
    Ballantyne CM; Hoogeveen RC; Bang H; Coresh J; Folsom AR; Heiss G; Sharrett AR
    Circulation; 2004 Feb; 109(7):837-42. PubMed ID: 14757686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study.
    Ballantyne CM; Hoogeveen RC; Bang H; Coresh J; Folsom AR; Chambless LE; Myerson M; Wu KK; Sharrett AR; Boerwinkle E
    Arch Intern Med; 2005 Nov; 165(21):2479-84. PubMed ID: 16314544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved identification of patients with coronary artery disease by the use of new lipid and lipoprotein biomarkers.
    Johnston N; Jernberg T; Lagerqvist B; Siegbahn A; Wallentin L
    Am J Cardiol; 2006 Mar; 97(5):640-5. PubMed ID: 16490429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local production of lipoprotein-associated phospholipase A2 and lysophosphatidylcholine in the coronary circulation: association with early coronary atherosclerosis and endothelial dysfunction in humans.
    Lavi S; McConnell JP; Rihal CS; Prasad A; Mathew V; Lerman LO; Lerman A
    Circulation; 2007 May; 115(21):2715-21. PubMed ID: 17502572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein-associated phospholipase A2 independently predicts the angiographic diagnosis of coronary artery disease and coronary death.
    May HT; Horne BD; Anderson JL; Wolfert RL; Muhlestein JB; Renlund DG; Clarke JL; Kolek MJ; Bair TL; Pearson RR; Sudhir K; Carlquist JF
    Am Heart J; 2006 Nov; 152(5):997-1003. PubMed ID: 17070179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein-associated phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke: the Rotterdam Study.
    Oei HH; van der Meer IM; Hofman A; Koudstaal PJ; Stijnen T; Breteler MM; Witteman JC
    Circulation; 2005 Feb; 111(5):570-5. PubMed ID: 15699277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease.
    Sabatine MS; Morrow DA; O'Donoghue M; Jablonksi KA; Rice MM; Solomon S; Rosenberg Y; Domanski MJ; Hsia J;
    Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2463-9. PubMed ID: 17766330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein-associated phospholipase A2 is associated with risk of dementia.
    van Oijen M; van der Meer IM; Hofman A; Witteman JC; Koudstaal PJ; Breteler MM
    Ann Neurol; 2006 Jan; 59(1):139-44. PubMed ID: 16278861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein-associated phospholipase A2 and measures of extracoronary atherosclerosis: the Rotterdam Study.
    Kardys I; Oei HH; van der Meer IM; Hofman A; Breteler MM; Witteman JC
    Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):631-6. PubMed ID: 16373603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.